Prevention strategies focus on managing underlying conditions and avoiding known triggers. For example, in HDN, Rh-negative mothers can receive Rh immunoglobulin to prevent the development of antibodies against Rh-positive fetal RBCs. In cases of drug-induced hemolysis, avoiding the offending medication is crucial.
